Press Release - 1997

Press Release - 1997

Sabinsa Corporation announces the development of a new product to its line of specialized nutraceuticals: Bis-Glycinato OxoVanadium (BGOV).

This new form of organically bound vanadium utilizes glycine as a carrier because of its key roles in the body - it is one of three amino acids forming glutathione and together with another amino acid, arginine, it produces creatine. Organic forms of vanadium are recognized as safer, more absorbable and deliver a therapeutic effect up to 50% greater that inorganic complexes, such as vanadyl sulphate.

Vanadium belongs to a group of biologically important metals like chromium, iron, cobalt, copper and zinc. A promising application for vanadium in human health emerges from recent studies evaluating vanadium as a substitute for insulin. It is thought to activate insulin receptors and through this effect exert insulin-like actions.

Vanadium is also discussed as a building material in bones and teeth, and is a popular ingredient found in many body building and sports nutrition formulations. This application may be due to the potential role of vanadium in thyroid functioning and in body metabolism.

 

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.